Publication | Open Access
A Novel Neoplastic Fusion Transcript, <i>RAD51AP1-DYRK4</i> , Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers
15
Citations
34
References
2020
Year
This discovery sheds light on a new area of molecular pathobiology of luminal B tumors and implies potential new therapeutic opportunities for more aggressive breast tumors overexpressing this fusion.
| Year | Citations | |
|---|---|---|
Page 1
Page 1